Back
Myriad Genetics Vs. Haemonetics Industry Stock Comparison
Sell
50
MYGN
Myriad Genetics
Last Price:
26.45
Seasonality Move:
9.99%
Buy
51
HAE
Haemonetics
Last Price:
77.85
Seasonality Move:
5%
Sell
50
Myriad Genetics (MYGN)
is a Sell
Is Myriad Genetics a Buy, Sell or Hold?
- The current Myriad Genetics [MYGN] share price is $26.47. The Score for MYGN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- MYGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Haemonetics (HAE)
is a Buy
Is Haemonetics a Buy, Sell or Hold?
- The current Haemonetics [HAE] share price is $77.89. The Score for HAE is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- HAE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MYGN Stock Price Chart
What is Myriad Genetics's stock price today?
-
The Myriad Genetics share price today is $26.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing selling pressure, which indicates risk of future bearish movement.
HAE Stock Price Chart
What is Haemonetics's stock price today?
-
The Haemonetics share price today is $77.89
The current trend is relatively stagnant and HAE is experiencing slight selling pressure.
MYGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 44.92 | Sell |
| Chaikin Money Flow: | -223397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.3 - 27.92) | Sell |
| Bollinger Bands (100): | (24.05 - 27.85) | Buy |
HAE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 52.7 | Buy |
| Chaikin Money Flow: | -10726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.83 - 78.07) | Buy |
| Bollinger Bands (100): | (76.18 - 89.62) | Sell |
MYGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.64 | Sell |
| 20-day SMA: | 27.1 | Sell |
| 50-day SMA: | 27.35 | Sell |
| 200-day SMA: | 23.47 | Buy |
| 8-day EMA: | 26.76 | Sell |
| 20-day EMA: | 27.01 | Sell |
| 50-day EMA: | 26.88 | Sell |
| 200-day EMA: | 24.08 | Buy |
HAE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 78.26 | Sell |
| 20-day SMA: | 76.26 | Buy |
| 50-day SMA: | 78.03 | Sell |
| 200-day SMA: | 82.54 | Sell |
| 8-day EMA: | 78.05 | Sell |
| 20-day EMA: | 77.16 | Buy |
| 50-day EMA: | 78.44 | Sell |
| 200-day EMA: | 82.32 | Sell |
Myriad Genetics Earnings Growth & MYGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.18 per share.
Haemonetics Earnings Growth & HAE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.64 per share.
Myriad Genetics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Haemonetics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||